In addition to wound healing and treating skin disorders, our faculty in the Division of Dermatology diagnose, treat, and prevent skin cancers. 

Notable achievements

  • National Registry for Ichthyosis and Related Disorders
  • Teledermatology programs
  • First FDA approved immunotherapy drug for Merkel cell carcinoma

Immunotherapy: Hope for Merkel cell carcinoma

Dr. Paul Nghiem is leading a clinical trial of an immunotherapy drug, pembrolizumab, where just over half of patients with advanced cancers saw their tumor shrink or disappear after receiving the immune-boosting drug.